Percutaneous microballoon compression for XXXX .

@entity1 @entity4254 @entity158
BACKGROUND: Percutaneous microballoon compression (PMC) for @entity4254 is an important therapeutic method. The aim of this study was to review the effects of PMC for @entity4254 in 276 @entity1 . METHODS: From December 2000 to May 2003, 276 @entity1 with @entity4254 were treated with PMC. The course of the disease ranged from 3 months to 38 years. Under the guidance of C-arm X-ray, 14# needle was placed into the foramen ovale using the classical Hakanson's technique. Fogarty balloon catheter was navigated into the Meckel's cave tenderly. A small amount of Omnipaque was slowly injected to inflate the balloon and compress the trigeminal ganglion for 3 to 10 minutes. RESULTS: A total of 290 PMC were performed on the 276 @entity1 . Among them, 252 had immediate relief from @entity158 . The @entity1 were followed up for a mean of 18.7 months (range, 4 to 32), 14 of them had a recurrence. Of the 14 @entity1 , 12 were re-operated with PMC, and the @entity158 was all controlled successfully. CONCLUSIONS: PMC is an effective and technically simple method for @entity4254 . For older @entity1 with @entity4254 , it may be the first choice.
